Dublin, April 05, 2017 -- Research and Markets has announced the addition of the "Global Heart Valve Devices Market: Analysis By Procedure, Replacement Procedure By Technique, Repair Procedure By Technique, By Region, By Country (2016-2021)" report to their offering.
Global Heart Valve Devices Market is forecasted to grow at a CAGR of 13.35% during 2016-2021. The strong growth in heart valve devices is driven by rising aging population, growth in population with heart disease and rising advances in minimally invasive technologies. Moreover, companies operating in this market are focusing on investments in R&D for continuous innovation and strengthening their positions in the market by targeted acquisitions and product expansions. Edwards Lifesciences, Medtronic, Abbott Laboratories and Boston Scientific are the major players in the market.
Demand for bioprosthetic is projected to display a faster growth than mechanical heart valve replacement techniques. However, technologically advanced techniques such as TAVR and TMVR are going to be the major growing sectors in the market. Among the regions, APAC is predicted to advance at the highest rate, mainly driven by the rising number of geriatric population, growing healthcare infrastructure and expansion in medical tourism.
Scope of the Report
The report provides coverage by Procedure, Technique, Region and Country:
By Procedure:
- Heart Valve Replacement Devices
- Heart Valve Repair Devices
Heart Valve Replacement Devices, By Technique:
- Mechanical Valve
- Bioprosthetic Valve
- TAVR (Transcatheter Aortic Valve Replacement)
Heart Valve Repair Devices, By Technique:
- Surgical Valve Repair Devices
- Balloon Valvuloplasty Devices
- TMVR (Transcatheter Mitral Valve Repair)
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
3.1 Increasing demand for Bioprosthetic Valve replacement techniques
3.2 Rapid transition towards Transcatheter Heart Valve therapies
3.3 Asia Pacific Region to witness the fastest growth in Heart Valve Devices Market in the forecast period
4. Heart Valve Devices Outlook
5. Global Heart Valve Devices Market: Growth and Forecast
6. Global Heart Valve Devices Market-By Procedure
7. Global Heart Valve Replacement Devices: By Technique
8. Global Heart Valve Devices Market: Regional Analysis
9. Market Dynamics
10. Market Trends
11. Porter's Five Forces Analysis - Heart Valve Devices Market
12. SWOT Analysis -Heart Valve Devices Market
13. Supply Chain Analysis
14. Competitive Landscape
14.1 Global Heart Valve Devices Market- Country Pricing and Volume Analysis (U.S., Germany, France, India)
14.2 Global Heart Valve Devices Market- Company Share Analysis
14.3 Product Benchmarking of Key Industry Players, By Procedure
14.4 Product Benchmarking of Key Industry Players in Heart Valve Replacement Procedure, By Technique
15. Policy and Regulatory Landscape
16. Company Profiles
- Abbott Laboratories
- Boston Scientific Corporation
- CryoLife Inc.
- Edwards Lifesciences Corporation
- JenaValve Technology Inc.
- LivaNova Plc
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- Neovasc Inc.
- St. Jude Medical Inc.
- TTK Healthcare
For more information about this report visit http://www.researchandmarkets.com/research/d787fw/global_heart
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Washington Post Publisher Will Lewis Steps Down After Layoffs
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anta Sports Expands Global Footprint With Strategic Puma Stake
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



